TOI
Oncology Institute IncNASDAQHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$458.92M
P/E Ratio
—
EPS
$-0.35
Beta
0.36
52W High
$4.88
52W Low
$2.02
50-Day MA
$3.55
200-Day MA
$3.47
Dividend Yield
—
Profit Margin
-7.97%
Forward P/E
—
PEG Ratio
—
About Oncology Institute Inc
Oncology Institute Inc (ticker: TOI) is a leading healthcare organization focused on revolutionizing cancer care through a comprehensive network of specialized clinics and cutting-edge treatment approaches. By utilizing advanced technologies and personalized treatment plans, TOI aims to improve patient outcomes while actively engaging in clinical trials and partnerships with top research institutions. Positioned in a rapidly evolving healthcare landscape, the company is well-equipped to capitalize on the increasing demand for innovative cancer therapies, supported by a strong pipeline and deep expertise in oncology.
Fundamentals
| Revenue (TTM) | $545.76M |
| Gross Profit (TTM) | $82.50M |
| EBITDA | $-25.91M |
| Operating Margin | -4.42% |
| Return on Equity | -652.00% |
| Return on Assets | -12.30% |
| Revenue/Share (TTM) | $5.54 |
| Book Value | $-0.16 |
| Price-to-Book | 0.76 |
| Price-to-Sales (TTM) | 0.84 |
| EV/Revenue | 0.978 |
| EV/EBITDA | 8.53 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 41.20% |
| Shares Outstanding | $99.98M |
| Float | $87.41M |
| % Insiders | 18.18% |
| % Institutions | 46.09% |
Historical Volatility
HV 10-Day
35.33%
HV 20-Day
50.80%
HV 30-Day
51.84%
HV 60-Day
70.56%
HV Rank
2.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($7.00 target)
1
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026